Core Revenue Generators
Drug Purchasing & Collective Rebate Revenue Program
Leverage collective scale to secure competitive pricing and optimize rebate capture, ensuring your practice remains financially robust regardless of patient volume.
Unlike traditional GPO models that primarily negotiate distributor pricing, AHG focuses on total infusion margin optimization. Our platform combines aggregated purchasing scale, infusion margin analytics, and a manufacturer rebate structure unique to the AHG network.
Where some biologic therapies that typically generate ~7% manufacturer rebates through standard purchasing channels can produce ~17% rebates within our network, significantly improving margins on high-utilization rheumatology therapies.
​
What This Means for Your Practice
• Access to the highest manufacturer rebate tiers
• No pressure to increase drug volume to unlock savings
• Predictable, maximized rebate revenue
• Maintain full ownership under your own Tax ID (fully independent model)
.jpg)
Infusion Suite Optimization
Turn clinical infusion services into a primary financial engine. We optimize workflows and operational throughput to enhance both patient care and clinical ROI.
Infusion centers play a crucial role in delivering a variety of medical therapies, including immunotherapy, antibiotic treatments and other intravenous medications. We aid in developing and managing infusion centers that provide an enhanced experience for the patient’s journey.
​
-
Infusion Protocol
-
Staffing & Training
-
Medication Inventory Strategy
-
Infusion Consent + Patient Education
Revenue Cycle Management
Master your practice economics by eliminating billing leaks and accelerating collections through our specialized, physician-led RCM processes.
We help medical practices optimize every stage of the revenue cycle. By combining advanced technology with comprehensive financial and operational data, we help practices improve collections, reduce revenue leakage, and strengthen profitability—driving results such as 26 average A/R days, 85% of A/R under 90 days, a 5% denial rate, prior authorization initiation within 24–48 hours, and 85% of infusion orders ready to schedule within 10 days.
​
-
Claim Management & Patient Collections
-
Payor Contracts & Provider Credentialing
-
Medical Coding & Training
-
Prior Authorization & Benefits Investigation
